ICON plc (ADR) (NASDAQ:ICLR)

CAPS Rating: 3 out of 5

The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.

Featured Broker Partners


Advertisement